arrow
K

Kotaro Shide

university of miyazaki
H指数:25
被引数:3,259

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The requirement of MALT1 activity for the growth of adult T cell leukemia/lymphoma

MALT1活性对于成人T细胞白血病/淋巴瘤生长的必要性

2026-07-230
OAAI
Impact of Cooperating Myeloid Gene Mutations on Disease Progression and Survival in Japanese MPN Patients: A Multicenter Study

合作髓系基因突变对日本MPN患者疾病进展和生存的影响:一项多中心研究

BLOOD
IF23.1
2024-11-050
PRE
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
2024-01-173
OAAI
Real-world clinical characteristics of post-essential thrombocythemia and post-polycythemia vera myelofibrosis

原发性血小板增多症后和真性红细胞增多症后骨髓纤维化的真实临床特征

2023-11-101
PRE
Nationwide prospective survey of secondary myelofibrosis in Japan: superiority of DIPSS-plus to MYSEC-PM as a survival risk model
2023-07-197
OAAI
Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
2023-02-169
OAAI
CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma
2022-11-295
OAAI
Prognosis of Indolent Adult T-Cell Leukemia/Lymphoma
2022-03-293
OAAI
Clonal hematopoiesis with JAK2V617F promotes pulmonary hypertension with ALK1 upregulation in lung neutrophils

JAK2V617F的克隆造血促进肺中性粒细胞ALK1上调的肺动脉高压

2021-10-2635
OAAI
Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
2021-07-1314
OAAI
Real-World Data on Clinical Features, Outcomes, and Prognostic Factors in Multiple Myeloma from Miyazaki Prefecture, Japan

来自日本宫崎县的多发性骨髓瘤临床特征,结果和预后因素的真实数据

2020-12-309
OAAI
Clinical significance of soluble CADM1 as a novel marker for adult T-cell leukemia/lymphoma
2020-02-136
OAAI
Mice with Calr mutations homologous to human CALR mutations only exhibit mild thrombocytosis
2019-03-2915
OAAI